Ultrasound Detection of Placental Insufficiency in Women With Elevated Second Trimester Serum Alpha-Fetoprotein or Human Chorionic Gonadotropin

Journal of Obstetrics and Gynaecology Canada

Volumn 30, Issue 3, 2008, Pages 198-206

  Toal, Meghana ^a   Chaddha, Vandana ^a   Windrim, Rory ^a   Kingdom, John ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Alpha fetoprotein; Human chorionic gonadotropin; Maternal serum screening; Perinatal outcome; Placental morphology; Prospective cohort study; Uterine artery Doppler

Indexed keywords

ALPHA FETOPROTEIN; CARDIOLIPIN ANTIBODY; CHORIONIC GONADOTROPIN;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BIRTH WEIGHT; CANADA; CESAREAN SECTION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLE; DOPPLER FLOWMETER; DOPPLER ULTRASONOGRAPHY; ECHOGRAPHY; FEMALE; FETUS DEATH; GESTATIONAL AGE; HELLP SYNDROME; HUMAN; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM SCREENING TEST; MORTALITY RATE; MULTIGRAVIDA; PERINATAL PERIOD; PLACENTA CIRCULATION; PLACENTA DISORDER; PLACENTA FUNCTION; PLACENTA INSUFFICIENCY; PREDICTIVE VALUE; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PROSPECTIVE STUDY; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SPINAL DYSRAPHISM; UTERINE ARTERY; ARTERY; BLOOD; DOPPLER FLOWMETRY; HIGH RISK PREGNANCY; METABOLISM; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY COMPLICATION; REPRODUCTION; STATISTICAL MODEL; UTERUS; VASCULARIZATION;

ADULT; ALPHA-FETOPROTEINS; ARTERIES; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; PLACENTAL INSUFFICIENCY; PLACENTATION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERUS;

EID: 44649125393     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32756-6     Document Type: Article

References (29)

1. Rankin J., Glinianaia S., Brown R., Renwick M. The changing prevalence of neural tube defects: a population-based study in the north of England, 1984-96. Northern Congenital Abnormality Survey Steering Group. Paediatr Perinat Epidemiol 2000, 14:104-110.
2. Khoshnood B., De Vigan C., Vodovar V., Goujard J., Goffinet F. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000. BJOG 2004, 111:485-490.
3. Waller D.K., Lustig L.S., Cunningham G.C., Golbus M.S., Hook E.B. Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death. N Engl J Med 1991, 325:6-10.
4. Lepage N., Chitayat D., Kingdom J., Huang T. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol 2003, 188:1354-1359.
5. Jauniaux E., Moscoso G., Campbell S., Gibb D., Driver M., Nicolaides K.H. Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum alpha-fetoprotein. Eur J Obstet Gynecol Reprod Biol 1990, 37:219-230.
6. Brownbill P., Mahendran D., Owen D., Swanson P., Thornburg K.L., Nelson D.M., et al. Denudations as paracellular routes for alphafetoprotein and creatinine across the human syncytiotrophoblast. Am J Physiol Regul Integr Comp Physiol 2000, 278(3):R677-R683.
7. Crocker I.P., Tansinda D.M., Baker P.N. Altered cell kinetics in cultured placental villous explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J Pathol 2004, 204(1):11-18.
8. Chitayat D., Farrell S.A., Huang T., Meier C., Wyatt P.R., Summers A.M. Double-positive maternal serum screening results for Down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes. Am J Obstet Gynecol 2002, 187:758-763.
9. Albaiges G., Missfelder-Lobos H., Lees C., Parra M., Nicolaides K.H. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000, 96:559-564.
10. Konchak P.S., Bernstein I.M., Capeless E.L. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am J Obstet Gynecol 1995, 173:1115-1119.
11. Bromley B., Frigoletto F.D., Harlow B.L., Pauker S., Benacerraf B.R. The role of Doppler velocimetry in the structurally normal second-trimester fetus with elevated levels of maternal serum alpha-fetoprotein. Ultrasound Obstet Gynecol 1994, 4:377-380.
12. Palacio M., Jauniaux E., Kingdom J., Dell E., Sheldrake A., Rodeck C.H. Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin. Ultrasound Obstet Gynecol 1999, 13:58-62.
13. Viero S., Chaddha V., Alkazaleh F., Simchen M.J., Malik A., Kelly E., et al. Prognostic value of placental ultrasound in pregnancies complicated by absent end-diastolic flow velocity in the umbilical arteries. Placenta 2004, 25:735-741.
14. Williams M.A., Hickok D.E., Zingheim R.W., Luthy D.A., Kimelman J., Nyberg D.A., et al. Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol 1992, 167:1032-1037.
15. Jauniaux E., Ramsay B., Campbell S. Ultrasonographic investigation of placental morphological characteristics and size during the second trimester of pregnancy. Am J Obstet Gynecol 1994, 170:130-137.
16. ACOG practice bulletin Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002, 77:67-75.
17. Alkazaleh F., Chaddha V., Viero S., Malik A., Anastasiades C., Sroka H., et al. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin. Am J Obstet Gynecol 2006, 194(3):821-827.
18. Toal M., Keating S., Machin G., Dodd J., Adamson S.L., Windrim R.W., et al. Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler. Am J Obstet Gynecol 2008, in press.
19. Dugoff L., Hobbins J.C., Malone F.D., Porter T.F., Luthy D., Comstock C.H., et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004, 191(4):1446-1451.
20. Krantz D., Goetzl L., Thom E., Zachary J., Hallahan T.W., Silver R., et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes (BUN Study Group). Am J Obstet Gynecol 2004, 191(4):1452-1458.
21. Platt L.D., Greene N., Johnson A., Zachary J., Thom E., Krantz D., et al. Sequential pathways of testing after first-trimester screening for trisomy 21. Obstet Gynecol 2004, 104(4):661-666.
22. Dugoff L., Canick J.A., Ball R.H., Nyberg D.A., Comstock C.H., Bukowski R., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353(19):2001-2011.
23. Dugoff L., Hobbins J.C., Malone F.D., Vidaver J., Sullivan L., Canick J.A., et al. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 2005, 106(2):260-267.
24. Whittle W., Chaddha V., Wyatt P., Huppertz B., Kingdom J. Ultrasound detection of placental insufficiency in women with 'unexplained' abnormal maternal serum screening results. Clin Genet 2006, 69(2):97-104.
25. Jauniaux E., Hempstock J., Greenwold N., Burton G.J. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003, 162(1):115-125.
26. Smith G.C., Stenhouse E.J., Crossley J.A., Aitken D.A., Cameron A.D., Connor J.M. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, pre-eclampsia and stillbirth. J Clin Endocrinol Metab 2002, 87:1762-1767.
27. Smith G.C., Crossley J.A., Aitken D.A., Pell J.P., Cameron A.D., Connor J.M., et al. First trimester placentation and the risk of antepartum stillbirth. JAMA 2004, 292:2249-2254.
28. Smith G.C., Shah I., Crossley J.A., Aitken D.A., Pell J.P., Nelson S.M., et al. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 2006, 107(1):161-166.
29. Audibert F., Benchimol Y., Benattar C., Champagne C., Frydman R. Prediction of pre-eclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry. Fetal Diagn Ther 2005, 20:48-53.